Chubb Hartford merger : Swiss insurer offers to acquire The Hartford for $23.2bn
(adsbygoogle = window.adsbygoogle || []).push({}); Chubb Hartford merger : Swiss property and casualty insurance company Chubb has offered to acquire The Hartford Financial Services Group for $65 More...
VectivBio begins phase 3 trial of apraglutide in short bowel syndrome
VectivBio has dosed the first patient in its phase 3 STARS clinical trial of its synthetic GLP-2 analog apraglutide in short bowel syndrome (SBS). The Swiss clinical-stage biotech company said that the STARS trial More...
VectivBio begins phase 3 trial of apraglutide in short bowel syndrome
VectivBio has dosed the first patient in its phase 3 STARS clinical trial of its synthetic GLP-2 analog apraglutide in short bowel syndrome (SBS). The Swiss clinical-stage biotech company said that the STARS trial More...
Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech
Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that More...
Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech
Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that More...
Boehringer Ingelheim to acquire NBE-Therapeutics for €1.1bn
German pharma company Boehringer Ingelheim has signed a deal worth €1.18 billion to acquire NBE-Therapeutics, a clinical-stage Switzerland-based biotech company, focused on developing antibody-drug conjugates More...
Boehringer Ingelheim to acquire NBE-Therapeutics for €1.1bn
German pharma company Boehringer Ingelheim has signed a deal worth €1.18 billion to acquire NBE-Therapeutics, a clinical-stage Switzerland-based biotech company, focused on developing antibody-drug conjugates More...
Elliott Advisors offers to take over Swiss food company Aryzta for CHF0.8 per share
Elliott Advisors (UK) has proposed to take over Swiss food company Aryzta for an indicative price of CHF 0.80 per share. According to Elliott Advisors (UK), the financing for the proposed deal is available and that More...
NEC to acquire Swiss fintech company Avaloq for $2.2bn
NEC acquisition of Avaloq : NEC Corporation, a Japanese IT and electronics company, has agreed to acquire Avaloq Group, a Swiss financial software company, for CHF 2.05 billion ($2.27 billion). Avaloq is a provider More...
Novartis reports positive results for Aimovig in phase 2 episodic migraine trial
Novartis said that a five-year phase 2 clinical trial of migraine prevention drug Aimovig (erenumab-aooe) has delivered strong long-term safety and efficacy results in patients with episodic migraine (EM). The results More...